ACLX – arcellx, inc. (US:NASDAQ)
Stock Stats
News
Arcellx (ACLX) Valuation Check After Wells Fargo Launches Coverage on Its Multiple Myeloma CAR-T Program [Yahoo! Finance]
Arcellx (NASDAQ:ACLX) was upgraded by analysts at Wells Fargo & Company to a "strong-buy" rating.
Arcellx (NASDAQ:ACLX) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating on the stock.
Arcellx: Funded Into 2028 With Strong Clinical Data [Seeking Alpha]
Arcellx (NASDAQ:ACLX) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They now have a $130.00 price target on the stock.
Form 8-K Arcellx, Inc. For: Dec 06
Form SCHEDULE 13G/A Arcellx, Inc. Filed by: T. Rowe Price Investment Management, Inc.
Form 4 Arcellx, Inc. For: Nov 17 Filed by: Heery Christopher
Form 10-Q Arcellx, Inc. For: Sep 30
Form 8-K Arcellx, Inc. For: Nov 05
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.